Highlights and Quick Summary
- Debt/Assets for the quarter ending June 30, 2022 was 33.2% (a 12.31% increase compared to previous quarter)
- Year-over-year quarterly Debt/Assets decreased by -47.07%
- Annual Debt/Assets for 2021 was 27.66% (a 45.04% increase from previous year)
- Annual Debt/Assets for 2020 was 19.07% (a -5.59% decrease from previous year)
- Annual Debt/Assets for 2019 was 20.2% (a 47.77% increase from previous year)
Visit stockrow.com/PTCT
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Debt/Assets of PTC Therapeutics, Inc.
Most recent Debt/Assetsof PTCT including historical data for past 10 years.Interactive Chart of Debt/Assets of PTC Therapeutics, Inc.
PTC Therapeutics, Inc. Debt/Assets for the past 10 Years (both Annual and Quarterly)
Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
---|---|---|---|---|---|
2022 | 33.2% | 29.56% | – | – | – |
2021 | 27.66% | 62.73% | 60.51% | 54.22% | 27.66% |
2020 | 45.83% | 45.38% | 22.85% | 20.35% | 19.07% |
2019 | 19.33% | 19.08% | 12.05% | 12.08% | 20.2% |
2018 | 13.67% | 14.67% | 29.09% | 38.71% | 13.67% |
2017 | 37.02% | 38.91% | 36.87% | 40.18% | 36.99% |
2016 | 36.46% | 33.6% | 31.07% | 27.85% | 36.46% |
2015 | 25.14% | 23.53% | 0.0% | 0.0% | 25.14% |
2014 | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
2013 | 0.03% | 0.05% | 1.57% | 6.4% | 0.03% |
2012 | 37.35% | 0.0% | 0.0% | 0.0% | 37.35% |
2011 | 26.44% | – | – | – | 26.48% |
Business Profile of PTC Therapeutics, Inc.
Sector: Healthcare
Industry: Biotechnology